I’m sure that is always a consideration and part of the big picture when building something from its infancy like a bio Co. Though he could get bought without; this may be more to catch the eye of institutional investment firms where the BIG MONEY starts joining this party and we see crazy gainers. Just my 2 cents. I’m sure anything and everything is on the table though.
We have to do some more research about how many different drugs/ antibiotics applications that vitastem will knockout and that’s how you find your best candidate for a buyer..